Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Bilypsa 4 Mg Tablet, 45 Tablets

₹ 1,450/Bottle

Dose2 mg
Packaging Size45 Tablets
ManufacturerZydus Cadila
FormTablet
Packaging TypePack
BrandBilypsa
Strength4 Mg
AvailabilityIn Stock
Bilypsa Tablet contains Saroglitazar, a dual action peroxisome proliferator-activated receptor (PPAR) inhibitor that aids in the management of high cholesterol, especially triglycerides, as well as blood sugar levels in people with type 2 diabetes.

Find products similar to Bilypsa 4 Mg Tablet, 45 Tablets

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNew Delhi
ShippingAs per delivery location

Product Image

Bilypsa 4 Mg Tablet, 45 Tablets-1Bilypsa 4 Mg Tablet, 45 Tablets-2Bilypsa 4 Mg Tablet, 45 Tablets-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
14-04-2022
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Sept 2022
GST
07CJLPK3654G1Z1
Laxmi Enterprises, founded in 2022, has established itself as a reliable and renowned name in the wholesale and Trader of Pharmaceutical products. Specializing in a broad range of pharmaceutical injections and tablets, the company is committed to providing high-quality, effective, and safe medicinal solutions. By focusing on customer satisfaction and upholding stringent quality standards, Laxmi Enterprises continues to serve the healthcare industry with dedication and professionalism. Their extensive product portfolio ensures they meet the diverse needs of healthcare providers, hospitals, and clinics.